Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene

A methylation and prognostic technology, applied in the direction of biochemical equipment and methods, microbial measurement/inspection, etc., can solve the problems of high cost

Pending Publication Date: 2020-07-07
LEPIDYNE CO LTD
View PDF7 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, such tests are relatively expensive and, therefore, burdensome when used as routine screening tests among the general public

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene
  • Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene
  • Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] Example 1. Selection of DMPs related to the pathogenesis of liver cancer

[0081] sample

[0082] Liver cancer samples were obtained from 184 liver cancer patients at Seoul National University Hospital to screen DNA methylated regions associated with liver cancer development. For normal tissues corresponding to liver cancer tissues, a normal control group was used.

[0083] Using a column-based DNA extraction method (PureLink TM Genomic DNA Mini Kit, Invitrogen; PureLink TM Genomic DNA Mini Kit, Invitrogen) and beads (Bead) method of DNA extraction (MagListo TM 5M Genomic DNA Extraction Kit, Bioneer; MagListo TM Genomic DNA (genomic DNA) was extracted from each sample using 5M Genomic DNA Extraction Kit (Bioni). The extracted genomic DNA was quantified using a spectrophotometer (nanodrop), and the state of the DNA was electrophoresed on a 1.5% agarose gel to confirm whether it was degraded or not.

[0084] bisulfite treatment

[0085] When the genomic DNA is trea...

Embodiment 2

[0094] Example 2. Selection of Diagnostic Marker Candidates

[0095] refer to figure 1 , DNA was extracted from 182 cases of liver cancer and corresponding normal liver samples, followed by InfiniumMethylation EPIC BeadChip.

[0096] Methylation data was analyzed by a self-built pipeline. Probes with a low degree of methylation under normal conditions and a high degree of methylation in tumors were selected.

[0097] First, DMPs showing methylation differences between normal and cancer samples were selected.

[0098] Select 7 probes with very low methylation status in normal samples and very high methylation of more than 50% in more than 70% of cancer patients, and have machine learning methods to verify the efficiency ( figure 1 ,blue).

[0099] Select probes whose methylation is very low (below 10%) in normal samples and high on average above 30% in liver cancer patients, and perform machine learning to select the probes that can effectively distinguish liver cancer / norm...

Embodiment 3

[0101] Example 3. Probe Selection by Heatmap

[0102] As a result of investigating the DNA methylation of 182 liver cancer samples and 127 normal samples, 100,053 DMP (differentially methylated probes, differently methylated probes) were selected from more than 5% of liver cancer samples that were overmethylated .

[0103] A very low 13,078 probes with methylation below 10% were selected from normal samples to enable blood biopsy in DMP showing differences between normal / cancer samples.

[0104] Among the selected probes, 7 probes with over 50% hypermethylation were selected from more than 70% of cancer patients (Table 1).

[0105] 【Table 1】

[0106] distinguish Probe ID Ratio of liver cancer with over 50% hypermethylation (%) Probe 1 cg20172627 78.16 Probe 2 cg22538054 77.59 Probe 3 cg27583690 74.14 Probe 4 cg19951303 72.99 Probe 5 cg22524657 71.84 Probe 6 cg24563094 70.11 Probe 7 cg25744484 70.11

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for assessing the prognosis or risk stratification of liver cancer by using a clinical specimen mixed with a normal tissue, wherein at least one CpG site thatshows a low methylation level in normal and blood tissues but a high methylation level in only a cancer tissue is measured for methylation level.

Description

technical field [0001] The invention relates to a method for measuring the degree of methylation of a specific gene CpG site, thereby assessing the risk of liver cancer. Background technique [0002] Cancer is a disease in which cell division cannot be controlled due to uncontrolled cell cycle, it infiltrates surrounding tissues and grows rapidly, and spreads or metastasizes to every part of the body, threatening life. [0003] Cancer that occurs in the liver is called liver cancer, and liver cancer is one of the cancers with a high incidence worldwide. In Korea, the death rate of liver cancer is very high at 23 per 100,000 people, and about 10% of the total death rate among Koreans is related to hepatitis, liver cirrhosis, and liver cancer. [0004] Liver cancer can be classified into metastatic liver cancer in which cancer of other tissues metastasizes to the liver and primary liver cancer (HCC; hepatocellular carcinoma) in which cancer develops from stem cells itself. Ho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/154C12Q2600/118C12Q2600/156C12Q2600/158
Inventor 金永峻金多元崔元荣李柾雨郑敏赫河静实金智元李娟受黄贞娥金泰裕林裕周
Owner LEPIDYNE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com